In the combination model (MELD + IL-38 ± CRP), a very good AUC ≈ 0.92 was achieved.<h4>Conclusion</h4>IL-38 reflects the severity of steatotic liver disease and is therefore a potentially predictive biomarker for early risk stratification and therapy monitoring. This evidence concerns the gene IL1F10 and liver disorder.